Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

China Sxt Pharmaceuticals Inc (SXTC)

China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 489
  • Shares Outstanding, K 457
  • Annual Sales, $ 1,970 K
  • Annual Income, $ -5,930 K
  • 60-Month Beta 1.00
  • Price/Sales 0.29
  • Price/Cash Flow N/A
  • Price/Book 0.10
Trade SXTC with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9401 +11.69%
on 04/18/24
3.3700 -68.84%
on 04/16/24
-0.6700 (-38.95%)
since 03/25/24
3-Month
0.9401 +11.69%
on 04/18/24
3.3700 -68.84%
on 04/16/24
-0.8500 (-44.74%)
since 01/25/24
52-Week
0.9401 +11.69%
on 04/18/24
9.3750 -88.80%
on 08/21/23
-3.7500 (-78.13%)
since 04/25/23

Most Recent Stories

More News
China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split

TAIZHOU, China, May 18, 2022 (GLOBE NEWSWIRE) --  China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty...

SXTC : 1.0500 (-1.87%)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

VYNT and SDIG are leading our lists

VYNT : 0.1940 (+7.78%)
AGRX : 0.3990 (-0.32%)
SXTC : 1.0500 (-1.87%)
ADGI : 4.64 (+0.87%)
DRCT : 6.13 (-1.79%)
Why Is China SXT Pharmaceuticals (SXTC) Stock Up Today?

Shares of SXTC stock are rising on extremely elevated volume

SXTC : 1.0500 (-1.87%)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

IGMS and NEO are leading our lists

SXTC : 1.0500 (-1.87%)
MEDS : 6.11 (-5.27%)
HYMC : 3.69 (-1.34%)
IGMS : 7.12 (-10.55%)
MOHO : 0.0999 (-42.72%)
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million

TAIZHOU, China, March 14, 2022 (GLOBE NEWSWIRE) --  China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical...

SXTC : 1.0500 (-1.87%)
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).

NEW YORK, NY / ACCESSWIRE / January 20, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China...

SXTC : 1.0500 (-1.87%)
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment

TAIZHOU, China, Jan. 20, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical...

SXTC : 1.0500 (-1.87%)
China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares

TAIZHOU, China, Jan. 18, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical...

SXTC : 1.0500 (-1.87%)
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares

TAIZHOU, China, Jan. 14, 2022 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC), a specialty pharmaceutical...

SXTC : 1.0500 (-1.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

China SXT Pharmaceuticals Inc. is a pharmaceutical company. It is involved in research, development, manufacturing, marketing and sales of traditional Chinese medicine pieces including advanced TCMP as well as fine and regular TCMP products. China SXT Pharmaceuticals Inc. is based in Jiangsu, China.

See More

Key Turning Points

3rd Resistance Point 1.1988
2nd Resistance Point 1.1611
1st Resistance Point 1.1155
Last Price 1.0500
1st Support Level 1.0322
2nd Support Level 0.9945
3rd Support Level 0.9489

See More

52-Week High 9.3750
Fibonacci 61.8% 6.1529
Fibonacci 50% 5.1575
Fibonacci 38.2% 4.1622
Last Price 1.0500
52-Week Low 0.9401

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar